Terms: = Gastric cancer AND AFF3, MLLT2-like, 3899, ENSG00000144218, LAF4, P51826 AND Diagnosis
1 results:
1. aff3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer.
Zeng Y; Zhang X; Li F; Wang Y; Wei M
J Clin Lab Anal; 2022 Jun; 36(6):e24437. PubMed ID: 35478418
[TBL] [Abstract] [Full Text] [Related]
